Check ties to lawmakers
Re “Reform, stat!,” editorial, March 7
I fully agree that a crackdown on inappropriate financial ties between drug makers and doctors is imperative. But how about a crackdown also on ties between drug makers and legislators?
In 2008, “Big Pharma” and medical device companies reportedly gave more than $28 million in campaign contributions to candidates. Rep. Henry A. Waxman, chairman of the House Energy and Commerce Committee, received contributions of $71,600 from the industry last year. Is that appropriate?
Richard E. Horowitz
Los Angeles
Get the L.A. Times Politics newsletter
Deeply reported insights into legislation, politics and policy from Sacramento, Washington and beyond. In your inbox three times per week.
You may occasionally receive promotional content from the Los Angeles Times.
